Expanding diagnostics company secures £1.5m investment
A York-based diagnostics company is targeting further growth after securing a £1.5m investment from NPIF - Mercia Equity Finance.
Abingdon Health specialises in ‘point of care’ tests, to diagnose disease in humans, animals and plants and to measure drugs, hormones and other biomarkers in a range of sample types.
These single use devices allow testing to be carried out on site, in the field or at home and the results are interpreted by eye or using smartphone apps and reader devices.
Abingdon develops and manufactures tes... You can carry on reading TheBusinessDesk.com for free, but you have reached the maximum number of pages an unregistered user can view. To register for an account, click here or login below...